type here...

CATEGORIES

Therapies and Therapists

LATEST

1234Page 3 of 4

TRENDING

EDITORS CHOICE

A Digital Turning Point in Migraine Care: CT-132 FDA Approval to Market is a Win for Patients and Proof that Clinical Evidence Matters

Gil Bashe, Medika Life Editor -
First Digital Health App United States Approval for Migraine Treatment with a Comprehensive Indication of Use

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne -
The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

Before Looking at the Results of the Paper on MDMA to Treat PTSD…

James Coyne -
So what really is the truth about MDMA and PTSD. Does this research published in Science hold up to scrutiny is is there a problem. Watch this space

The Remarkable Research Of CAR T Therapy: B Cell Cancers

William Haseltine, PhD -
The first installment lays the foundation for understanding how CAR T works. This second piece delves into the use of CAR T to treat B cell cancers.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories